Home Telemonitoring System for Diabetic Patients: a randomised controlled crossover study.
Not Applicable
- Conditions
- diabetes mellitus
- Registration Number
- JPRN-UMIN000011219
- Lead Sponsor
- Kanazawa University Hospital,Department of Endocrinology and Metabolism
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with malignant hypertension or secondary hypertension 2) Diabetic patients requiring insulin therapy 3) Pregnant and probably pregnant patients 4) patients with abnormal serum creatinin value 5) Patients with severe hepatic dysfunction 6) Patients who had myocardial infarction or apoplexy within 3 months before the satrt of the study or who are treated. 7) Patients with severe allergy or with steroid therapy 8) Patients with pancreatitis or pasthistory of pancreatitis 9) Patients with malignacy 10) Other patients judged as being inappropriate for the subjects of the study by investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Following items at every 3 months 1 changes in plasma glucose level and HbA1C 2 Changes in urine alubumin excretion 3 Changes in lipid levels 4 Changes in blood pressure 5 Changes in body weight and body mass index(BMI) 6 Occurrence of diabetic complication 7 Newly required medicine for diabetes, blood pressure, or dyslipidemia
- Secondary Outcome Measures
Name Time Method